Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06161831
Other study ID # AAAT1572_2
Secondary ID R33CA253604
Status Recruiting
Phase N/A
First received
Last updated
Start date April 22, 2024
Est. completion date July 31, 2026

Study information

Verified date May 2024
Source Columbia University
Contact Melissa S Stockwell, MD MPH
Phone 212-342-5732
Email mss2112@cumc.columbia.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This RCT will take place at health centres and their affiliated schools and community immunization centers overseen by the Kampala Capital City Authority (KCCA) as well as at the Makerere/Mulago/Columbia Adolescent Health Clinic in Kampala. The investigators will assess the impact of vaccine text message and automated phone reminders on human papillomavirus (HPV) vaccination initiation and completion.


Description:

Cervical cancer is the leading female cancer in Uganda. HPV is the principal cause of cervical cancer. The national HPV vaccination program in Uganda includes preteen/ adolescent girls. Vaccinations are provided within schools or through community health centers. However, in Kampala, HPV vaccination especially series completion is low. While research regarding the use of text message vaccine reminders is strong in the U.S., their use has not been demonstrated in a preteen/adolescent population in Sub-Saharan Africa and other low and middle income countries (LMICs) in a full RCT. In this study, RCT caregivers of preteens/adolescents will be randomized and stratified by site, language and HPV vaccine dose needed (initiation vs. completion). Intervention families will receive text message or automated phone reminders based on family preference.


Recruitment information / eligibility

Status Recruiting
Enrollment 396
Est. completion date July 31, 2026
Est. primary completion date May 31, 2026
Accepts healthy volunteers No
Gender Female
Age group 10 Years to 14 Years
Eligibility Inclusion Criteria: - Be a parenting adult of an adolescent girl aged 10-14 years - Reside in Kampala and/or the surrounding districts - Speak English or Luganda - Have a cell phone with text messaging capability - Must have ability to consent Exclusion Criteria: - Parenting adult speaks other language than English or Luganda only - Parenting adult already enrolled in the study for another child - Participation in previous HPV vaccine reminder study

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Text Message/automated phone reminder
Receipt of text message or automated phone reminders notifying when the next HPV vaccine dose is due (either first or second)

Locations

Country Name City State
Uganda Makerere University/Mulago Hospital Kampala
United States Columbia University Irving Medical Center New York New York

Sponsors (3)

Lead Sponsor Collaborator
Columbia University Makerere University, National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Uganda, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time to Receipt of First HPV Vaccine Dose Timeliness of vaccination (time to event) will be measured 12 months
Primary Time to Receipt of Second HPV Vaccine Dose Timeliness of vaccination (time to event) will be measured 12 months
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT05658198 - Investigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural Mississippi
Completed NCT05804825 - Testing the Persuasiveness of Pro-inoculation Arguments N/A
Enrolling by invitation NCT03592225 - Can an Educational Intervention Targeting General Practitioners Increase HPV Vaccination Coverage in AuRA_Lyon (France) N/A
Completed NCT04576962 - County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana
Completed NCT05151367 - SMS HPV Vaccine Reminders N/A
Completed NCT01284374 - Parent-son-provider Decision-making About HPV Vaccination N/A